Dr. Redjal on Technological Advances in Neurosurgical Oncology

Video

In Partnership With:

Navid Redjal, MD, FAANS, discusses technological advances that have impacted neurosurgical oncology.

Navid Redjal, MD, FAANS, director, Neurosurgical Oncology, Capital Institute for Neurosciences, Capital Health Cancer Institute, discusses technological advances that have impacted neurosurgical oncology.

Recent technological developments have drastically altered neurosurgeons approach the care of patients with cancer, Redjal says. For instance, stereotactic radiosurgery has replaced typical surgery in approximately 40% of patients, Redjal adds. Stereotactic radiosurgery is a noninvasive procedure used to deliver radiation to small tumors through non-surgical means.

Additionally, intraoperative planning has allowed surgeons to utilize minimally invasive techniques for patients with tumors that could potentially lead to significant morbidity and cause neurologic disfunction, Redjal concludes.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS